We investigated whether discrepancies between our results of miR655 as an EMT promoter in miR655 over-expressing breast cancer cells and other reports of miR655 being an EMT suppressor in cancer cell lines exhibiting TGF-β-induced EMT43 could be explained by subversion to COX2/EP4 pathway. This evidence concerns the gene PTGS2 and breast cancer.